Modern oncology is increasingly focused on treatments that help the immune system fight cancer more effectively. One of these methods, dendritic cell therapy for breast cancer, is designed to train immune cells to recognize tumor-specific markers based on the patient’s individual condition. This personalized approach can offer a more targeted strategy compared to standard treatment methods. Access to such therapies often requires cooperation with specialized international clinics experienced in advanced immunotherapy. Patients usually receive coordinated medical support, treatment recommendations, and assistance with appointments, travel, and communication throughout the process.